We reviewed pexacerfont in one study, a 3-week trial of 51 Iranian men within residential treatment camps where treatment is not normally provided [52]. Dosing was tapered from 300 mg po OD for the first week, to 200 mg po OD in Week 2 and 100 mg po OD in Week 3. While measures of craving reduced significantly more in the treatment arm than placebo, there was no difference in end-of-treatment abstinence between groups. Additionally, levels of temptation and depression, but not anxiety, withdrawal severity, or treatment effectiveness, improved favouring treatment.
Data extraction
However, it is not well-documented yet if BCBT is superior to pharmacological treatments for amphetamine abuse or a combination of the two treatments can work better. In previous reviews, we have extensively described the efficacy and safety of stimulant and non-stimulant drugs used in the management of ADHD and compared the relative merits of each (Heal et al., 2009, 2012). This analysis has revealed that the stimulants, including amphetamine, are still accepted to be the most efficacious drugs available. Some attempts to introduce new medications, for example guanfacine XR (Intuniv®) have been successful, but many other new pharmacological approaches have failed (see Heal et al., 2012).
Kratom Uses, Risks & Addiction Treatment
Providers may also use amphetamines to treat obesity, though this is less common. People who habitually use amphetamines rapidly develop tolerance as part of dependence. The amount ultimately used may be more than several times the original dose. Most people using very high doses over several days or weeks become confused and psychotic because amphetamines can cause severe anxiety, paranoia, and a distorted sense of reality. Sometimes called the “opioid epidemic,” addiction to opioid prescription pain medicines has reached an alarming rate across the United States. Some people who’ve been using opioids over a long period of time may need physician-prescribed temporary or long-term drug substitution during treatment.
- People should discard medications that are past their expiration date safely through Food and Drug Administration collection sites or by following government guidelines.
- Some side effects of amphetamine may occur that usually do not need medical attention.
- Talk with your healthcare provider if you feel like you are dependent on amphetamines or if they are not working to alleviate your symptoms.
- Patients should be asked what drug(s) they used, the route of administration they utilized, and the duration of their drug use.
A clinical perspective on the use of amphetamine in the treatment of ADHD
Although most of these experiments have looked at the effects of amphetamine isomers on basal [3H]monoamine release from synaptosomes or slices, amphetamine also augments electrically stimulated efflux (Easton et al., 2007). This action indicates that its retro-transport mechanism can act both co-operatively with, and independently of, neuronal firing. For people with addictions to drugs like stimulants or cannabis, no medications are currently available to assist in treatment, so treatment consists of behavioral therapies. Treatment should be tailored to address each patient’s drug use patterns and drug-related medical, mental, and social problems. Amphetamines including methamphetamine (MA) are a global health problem and there is concern that amphetamines abuse will continue, despite awareness of multiple harms [1]. After cannabis, amphetamines are the most commonly consumed illicit substances in the world [2].
In a separate study, topiramate (200 mg po OD) for MA dependence was examined in 62 males and analysed in 57, who were all on prescribed methadone for opiate replacement therapy [55], with the outcomes of interest being dependence severity, cravings, depression and MA use. There was a statistically significant difference between groups on the Addiction Severity Index (drug use severity and drug need domains) that favoured the topiramate arm; however, there was amphetamine addiction no statistically significant difference in cravings or depression symptoms between the study groups. Participants randomised to topiramate returned significantly fewer MA-positive UDS at Week 6, but this result was not sustained throughout the final 4 weeks of the treatment period [55]. Risk of bias in individual study methods and reporting are included in Supplementary Table 1 and Supplementary Data (see ESM) as considerations across a number of domains.
